Compare OCUL & AFYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCUL | AFYA |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2014 | 2019 |
| Metric | OCUL | AFYA |
|---|---|---|
| Price | $6.29 | $14.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 8 |
| Target Price | ★ $26.00 | $17.24 |
| AVG Volume (30 Days) | ★ 3.5M | 426.4K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 4.65% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,990,000.00 | N/A |
| Revenue This Year | $1.71 | $7.66 |
| Revenue Next Year | $93.12 | $7.06 |
| P/E Ratio | ★ N/A | $9.30 |
| Revenue Growth | ★ 3.48 | N/A |
| 52 Week Low | $6.23 | $11.62 |
| 52 Week High | $16.44 | $16.16 |
| Indicator | OCUL | AFYA |
|---|---|---|
| Relative Strength Index (RSI) | 26.48 | 63.47 |
| Support Level | $6.23 | $13.43 |
| Resistance Level | $9.93 | $14.85 |
| Average True Range (ATR) | 0.42 | 0.44 |
| MACD | -0.05 | 0.18 |
| Stochastic Oscillator | 15.36 | 98.52 |
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.